Ibnsina Pharma Co SAE EGX:ISPH:
IBNSINA PHARMA QTRLY CONSOL NET PROFIT EGP 255.9 MILLION
IBNSINA PHARMA QTRLY CONSOL NET SALES EGP 20.50 BILLION
Ibnsina Pharma Qtrly Consol Profit EGP 255.9 Mln
Earlier from Ibnsina Pharma
- Ibnsina Pharma FY Consol Profit EGP 951.8 Mln
- Gulf stocks end lower on weak oil prices; Saudi leads decline
- ZAWYA-SNG: Egypt: EBRD provides $27.6mln financing to Ibnsina Pharma for new warehouse
- Ibnsina Pharma Gets EGP 1.3 Bln Loan From EBRD To Finance Green Warehouse